Companion Diagnostic Market Report

Japan Companion Diagnostic Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 17, 2019
  • PAGES：198
  • REPORT CODE：GMM285295
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Companion Diagnostic market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Companion Diagnostic market. Detailed analysis of key players, along with key growth strategies adopted by Companion Diagnostic industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Cancer Genetics

    • Celera Corporation

    • Atossa Genetics

    • Agendia

    • Agena Biosciences

    • Admera Health

    • AstraZeneca

    • Becton Dickinson


    By Type:

    • ViroSeqR HIV-1 Genotyping System

    • ViroSeqR HIV-1 Integrase Assay

    • ViroSeqR HCV Assay

    • ViroSeqR HBV Assay

    • Cystic Fibrosis Genotyping Assay

    • LDL-S3GGER Test


    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Companion Diagnostic Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Companion Diagnostic Market Size and Growth Rate of ViroSeqR HIV-1 Genotyping System from 2014 to 2026

      • 1.3.2 Japan Companion Diagnostic Market Size and Growth Rate of ViroSeqR HIV-1 Integrase Assay from 2014 to 2026

      • 1.3.3 Japan Companion Diagnostic Market Size and Growth Rate of ViroSeqR HCV Assay from 2014 to 2026

      • 1.3.4 Japan Companion Diagnostic Market Size and Growth Rate of ViroSeqR HBV Assay from 2014 to 2026

      • 1.3.5 Japan Companion Diagnostic Market Size and Growth Rate of Cystic Fibrosis Genotyping Assay from 2014 to 2026

      • 1.3.6 Japan Companion Diagnostic Market Size and Growth Rate of LDL-S3GGER Test from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Companion Diagnostic Market Size and Growth Rate of Application 1 from 2014 to 2026

      • 1.4.2 Japan Companion Diagnostic Market Size and Growth Rate of Application 2 from 2014 to 2026

      • 1.4.3 Japan Companion Diagnostic Market Size and Growth Rate of Application 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Companion Diagnostic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Companion Diagnostic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Companion Diagnostic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Companion Diagnostic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Companion Diagnostic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Companion Diagnostic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Companion Diagnostic Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Companion Diagnostic Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Companion Diagnostic Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Companion Diagnostic by Major Types

      • 3.4.1 Market Size and Growth Rate of ViroSeqR HIV-1 Genotyping System

      • 3.4.2 Market Size and Growth Rate of ViroSeqR HIV-1 Integrase Assay

      • 3.4.3 Market Size and Growth Rate of ViroSeqR HCV Assay

      • 3.4.4 Market Size and Growth Rate of ViroSeqR HBV Assay

      • 3.4.5 Market Size and Growth Rate of Cystic Fibrosis Genotyping Assay

      • 3.4.6 Market Size and Growth Rate of LDL-S3GGER Test

    4 Segmentation of Companion Diagnostic Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Companion Diagnostic by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Companion Diagnostic in Application 1

      • 4.4.2 Market Size and Growth Rate of Companion Diagnostic in Application 2

      • 4.4.3 Market Size and Growth Rate of Companion Diagnostic in Application 3


    5 Market Analysis by Regions

    • 5.1 Japan Companion Diagnostic Production Analysis by Regions

    • 5.2 Japan Companion Diagnostic Consumption Analysis by Regions


    6 Hokkaido Companion Diagnostic Landscape Analysis

    • 6.1 Hokkaido Companion Diagnostic Landscape Analysis by Major Types

    • 6.2 Hokkaido Companion Diagnostic Landscape Analysis by Major End-Users


    7 Tohoku Companion Diagnostic Landscape Analysis

    • 7.1 Tohoku Companion Diagnostic Landscape Analysis by Major Types

    • 7.2 Tohoku Companion Diagnostic Landscape Analysis by Major End-Users


    8 Kanto Companion Diagnostic Landscape Analysis

    • 8.1 Kanto Companion Diagnostic Landscape Analysis by Major Types

    • 8.2 Kanto Companion Diagnostic Landscape Analysis by Major End-Users


    9 Chubu Companion Diagnostic Landscape Analysis

    • 9.1 Chubu Companion Diagnostic Landscape Analysis by Major Types

    • 9.2 Chubu Companion Diagnostic Landscape Analysis by Major End-Users


    10 Kinki Companion Diagnostic Landscape Analysis

    • 10.1 Kinki Companion Diagnostic Landscape Analysis by Major Types

    • 10.2 Kinki Companion Diagnostic Landscape Analysis by Major End-Users


    11 Chugoku Companion Diagnostic Landscape Analysis

    • 11.1 Chugoku Companion Diagnostic Landscape Analysis by Major Types

    • 11.2 Chugoku Companion Diagnostic Landscape Analysis by Major End-Users


    12 Shikoku Companion Diagnostic Landscape Analysis

    • 12.1 Shikoku Companion Diagnostic Landscape Analysis by Major Types

    • 12.2 Shikoku Companion Diagnostic Landscape Analysis by Major End-Users


    13 Kyushu Companion Diagnostic Landscape Analysis

    • 13.1 Kyushu Companion Diagnostic Landscape Analysis by Major Types

    • 13.2 Kyushu Companion Diagnostic Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Cancer Genetics

      • 14.1.1 Cancer Genetics Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Celera Corporation

      • 14.2.1 Celera Corporation Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Atossa Genetics

      • 14.3.1 Atossa Genetics Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Agendia

      • 14.4.1 Agendia Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Agena Biosciences

      • 14.5.1 Agena Biosciences Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Admera Health

      • 14.6.1 Admera Health Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 AstraZeneca

      • 14.7.1 AstraZeneca Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Becton Dickinson

      • 14.8.1 Becton Dickinson Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 81 Figures and 137 Tables)

     

    • Figure Japan Companion Diagnostic Market Size and Growth Rate of ViroSeqR HIV-1 Genotyping System from 2014 to 2026

    • Figure Japan Companion Diagnostic Market Size and Growth Rate of ViroSeqR HIV-1 Integrase Assay from 2014 to 2026

    • Figure Japan Companion Diagnostic Market Size and Growth Rate of ViroSeqR HCV Assay from 2014 to 2026

    • Figure Japan Companion Diagnostic Market Size and Growth Rate of ViroSeqR HBV Assay from 2014 to 2026

    • Figure Japan Companion Diagnostic Market Size and Growth Rate of Cystic Fibrosis Genotyping Assay from 2014 to 2026

    • Figure Japan Companion Diagnostic Market Size and Growth Rate of LDL-S3GGER Test from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Companion Diagnostic Market Size and Growth Rate of Application 1 from 2014 to 2026

    • Figure Japan Companion Diagnostic Market Size and Growth Rate of Application 2 from 2014 to 2026

    • Figure Japan Companion Diagnostic Market Size and Growth Rate of Application 3 from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Companion Diagnostic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Companion Diagnostic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Companion Diagnostic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Companion Diagnostic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Companion Diagnostic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Companion Diagnostic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Companion Diagnostic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Companion Diagnostic Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Companion Diagnostic Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Companion Diagnostic

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Companion Diagnostic by Different Types from 2014 to 2026

    • Table Consumption Share of Companion Diagnostic by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of ViroSeqR HIV-1 Genotyping System

    • Figure Market Size and Growth Rate of ViroSeqR HIV-1 Integrase Assay

    • Figure Market Size and Growth Rate of ViroSeqR HCV Assay

    • Figure Market Size and Growth Rate of ViroSeqR HBV Assay

    • Figure Market Size and Growth Rate of Cystic Fibrosis Genotyping Assay

    • Figure Market Size and Growth Rate of LDL-S3GGER Test

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Companion Diagnostic by Different End-Users from 2014 to 2026

    • Table Consumption Share of Companion Diagnostic by Different End-Users from 2014 to 2026

    • Figure Japan Companion Diagnostic Market Size and Growth Rate of Application 1 from 2014 to 2026

    • Figure Japan Companion Diagnostic Market Size and Growth Rate of Application 2 from 2014 to 2026

    • Figure Japan Companion Diagnostic Market Size and Growth Rate of Application 3 from 2014 to 2026

    • Table Japan Companion Diagnostic Production by Regions

    • Table Japan Companion Diagnostic Production Share by Regions

    • Figure Japan Companion Diagnostic Production Share by Regions in 2014

    • Figure Japan Companion Diagnostic Production Share by Regions in 2018

    • Figure Japan Companion Diagnostic Production Share by Regions in 2026

    • Table Japan Companion Diagnostic Consumption by Regions

    • Table Japan Companion Diagnostic Consumption Share by Regions

    • Figure Japan Companion Diagnostic Consumption Share by Regions in 2014

    • Figure Japan Companion Diagnostic Consumption Share by Regions in 2018

    • Figure Japan Companion Diagnostic Consumption Share by Regions in 2026

    • Table Hokkaido Companion Diagnostic Consumption by Types from 2014 to 2026

    • Table Hokkaido Companion Diagnostic Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Companion Diagnostic Consumption Share by Types in 2014

    • Figure Hokkaido Companion Diagnostic Consumption Share by Types in 2018

    • Figure Hokkaido Companion Diagnostic Consumption Share by Types in 2026

    • Table Hokkaido Companion Diagnostic Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Companion Diagnostic Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Companion Diagnostic Consumption Share by End-Users in 2014

    • Figure Hokkaido Companion Diagnostic Consumption Share by End-Users in 2018

    • Figure Hokkaido Companion Diagnostic Consumption Share by End-Users in 2026

    • Table Tohoku Companion Diagnostic Consumption by Types from 2014 to 2026

    • Table Tohoku Companion Diagnostic Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Companion Diagnostic Consumption Share by Types in 2014

    • Figure Tohoku Companion Diagnostic Consumption Share by Types in 2018

    • Figure Tohoku Companion Diagnostic Consumption Share by Types in 2026

    • Table Tohoku Companion Diagnostic Consumption by End-Users from 2014 to 2026

    • Table Tohoku Companion Diagnostic Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Companion Diagnostic Consumption Share by End-Users in 2014

    • Figure Tohoku Companion Diagnostic Consumption Share by End-Users in 2018

    • Figure Tohoku Companion Diagnostic Consumption Share by End-Users in 2026

    • Table Kanto Companion Diagnostic Consumption by Types from 2014 to 2026

    • Table Kanto Companion Diagnostic Consumption Share by Types from 2014 to 2026

    • Figure Kanto Companion Diagnostic Consumption Share by Types in 2014

    • Figure Kanto Companion Diagnostic Consumption Share by Types in 2018

    • Figure Kanto Companion Diagnostic Consumption Share by Types in 2026

    • Table Kanto Companion Diagnostic Consumption by End-Users from 2014 to 2026

    • Table Kanto Companion Diagnostic Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Companion Diagnostic Consumption Share by End-Users in 2014

    • Figure Kanto Companion Diagnostic Consumption Share by End-Users in 2018

    • Figure Kanto Companion Diagnostic Consumption Share by End-Users in 2026

    • Table Chubu Companion Diagnostic Consumption by Types from 2014 to 2026

    • Table Chubu Companion Diagnostic Consumption Share by Types from 2014 to 2026

    • Figure Chubu Companion Diagnostic Consumption Share by Types in 2014

    • Figure Chubu Companion Diagnostic Consumption Share by Types in 2018

    • Figure Chubu Companion Diagnostic Consumption Share by Types in 2026

    • Table Chubu Companion Diagnostic Consumption by End-Users from 2014 to 2026

    • Table Chubu Companion Diagnostic Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Companion Diagnostic Consumption Share by End-Users in 2014

    • Figure Chubu Companion Diagnostic Consumption Share by End-Users in 2018

    • Figure Chubu Companion Diagnostic Consumption Share by End-Users in 2026

    • Table Kinki Companion Diagnostic Consumption by Types from 2014 to 2026

    • Table Kinki Companion Diagnostic Consumption Share by Types from 2014 to 2026

    • Figure Kinki Companion Diagnostic Consumption Share by Types in 2014

    • Figure Kinki Companion Diagnostic Consumption Share by Types in 2018

    • Figure Kinki Companion Diagnostic Consumption Share by Types in 2026

    • Table Kinki Companion Diagnostic Consumption by End-Users from 2014 to 2026

    • Table Kinki Companion Diagnostic Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Companion Diagnostic Consumption Share by End-Users in 2014

    • Figure Kinki Companion Diagnostic Consumption Share by End-Users in 2018

    • Figure Kinki Companion Diagnostic Consumption Share by End-Users in 2026

    • Table Chugoku Companion Diagnostic Consumption by Types from 2014 to 2026

    • Table Chugoku Companion Diagnostic Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Companion Diagnostic Consumption Share by Types in 2014

    • Figure Chugoku Companion Diagnostic Consumption Share by Types in 2018

    • Figure Chugoku Companion Diagnostic Consumption Share by Types in 2026

    • Table Chugoku Companion Diagnostic Consumption by End-Users from 2014 to 2026

    • Table Chugoku Companion Diagnostic Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Companion Diagnostic Consumption Share by End-Users in 2014

    • Figure Chugoku Companion Diagnostic Consumption Share by End-Users in 2018

    • Figure Chugoku Companion Diagnostic Consumption Share by End-Users in 2026

    • Table Shikoku Companion Diagnostic Consumption by Types from 2014 to 2026

    • Table Shikoku Companion Diagnostic Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Companion Diagnostic Consumption Share by Types in 2014

    • Figure Shikoku Companion Diagnostic Consumption Share by Types in 2018

    • Figure Shikoku Companion Diagnostic Consumption Share by Types in 2026

    • Table Shikoku Companion Diagnostic Consumption by End-Users from 2014 to 2026

    • Table Shikoku Companion Diagnostic Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Companion Diagnostic Consumption Share by End-Users in 2014

    • Figure Shikoku Companion Diagnostic Consumption Share by End-Users in 2018

    • Figure Shikoku Companion Diagnostic Consumption Share by End-Users in 2026

    • Table Kyushu Companion Diagnostic Consumption by Types from 2014 to 2026

    • Table Kyushu Companion Diagnostic Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Companion Diagnostic Consumption Share by Types in 2014

    • Figure Kyushu Companion Diagnostic Consumption Share by Types in 2018

    • Figure Kyushu Companion Diagnostic Consumption Share by Types in 2026

    • Table Kyushu Companion Diagnostic Consumption by End-Users from 2014 to 2026

    • Table Kyushu Companion Diagnostic Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Companion Diagnostic Consumption Share by End-Users in 2014

    • Figure Kyushu Companion Diagnostic Consumption Share by End-Users in 2018

    • Figure Kyushu Companion Diagnostic Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Cancer Genetics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cancer Genetics

    • Figure Sales and Growth Rate Analysis of Cancer Genetics

    • Figure Revenue and Market Share Analysis of Cancer Genetics

    • Table Product and Service Introduction of Cancer Genetics

    • Table Company Profile and Development Status of Celera Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celera Corporation

    • Figure Sales and Growth Rate Analysis of Celera Corporation

    • Figure Revenue and Market Share Analysis of Celera Corporation

    • Table Product and Service Introduction of Celera Corporation

    • Table Company Profile and Development Status of Atossa Genetics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Atossa Genetics

    • Figure Sales and Growth Rate Analysis of Atossa Genetics

    • Figure Revenue and Market Share Analysis of Atossa Genetics

    • Table Product and Service Introduction of Atossa Genetics

    • Table Company Profile and Development Status of Agendia

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agendia

    • Figure Sales and Growth Rate Analysis of Agendia

    • Figure Revenue and Market Share Analysis of Agendia

    • Table Product and Service Introduction of Agendia

    • Table Company Profile and Development Status of Agena Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agena Biosciences

    • Figure Sales and Growth Rate Analysis of Agena Biosciences

    • Figure Revenue and Market Share Analysis of Agena Biosciences

    • Table Product and Service Introduction of Agena Biosciences

    • Table Company Profile and Development Status of Admera Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Admera Health

    • Figure Sales and Growth Rate Analysis of Admera Health

    • Figure Revenue and Market Share Analysis of Admera Health

    • Table Product and Service Introduction of Admera Health

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Becton Dickinson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Becton Dickinson

    • Figure Sales and Growth Rate Analysis of Becton Dickinson

    • Figure Revenue and Market Share Analysis of Becton Dickinson

    • Table Product and Service Introduction of Becton Dickinson

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US